Israeli cybersecurity startups continue to attract significant investments, even in their early stages. Act Security, a new venture by the founders of Medigate, has successfully raised $40 million in a Series A funding round, just four months after securing a $20 million Seed round. This brings their total funding to $60 million since the company’s inception. Act Security focuses on developing a platform to secure cloud infrastructure and data centers and currently has a team of 30 employees. The recent funding round was led by U.S.-based Notable Capital, with contributions from Startpoint Capital, Claltech, Access’s technology investment arm in Israel, and existing investors such as Bessemer Venture Partners, Team8, Hetz Ventures, and Brightmind. The leadership team includes Jonathan Langer as CEO, Itay Kirshenbaum as Chief Technology Officer, Stephen Goldberg as Chief Product Officer, and Ilai Fallach as Chief R&D Officer. Notably, Langer and Kirshenbaum previously co-founded Medigate, a startup focused on medical device security, which was acquired by Claroty in 2021 for around $400 million.
How did the founders of Medigate secure $60 million for their new cyber startup so quickly?
